World AIDS Day and the Fight Against HIV: Discovering and Developing Emtricitabine
Tuesday, November 28, 2017
AIDS has killed more than 36 million people worldwide making it one of the most important global public health issues in recorded history according to the Worlds Health Organization and despite recent improved access to antiretroviral treatment in many regions of the world, the AIDS epidemic claims an estimated 2 million lives each year. Dennis Liotta who is Associate Director of The Emory Center for AIDS Research has helped to transform HIV/AIDS from a death sentence to a chronic infection in which patients are able to live active, near normal lives. It is estimated that greater than ninety percent of all of the HIV-infected persons in the United States take or have taken one of the drugs he invented. Join Dennis Liotta for this special broadcast commemorating of World AIDS Day as he illuminates us regarding the discovery and development of Emtricitabine and discover why chance does indeed favor the prepared mind.
What You Will Learn
- Why good science is necessary, but not sufficient, to bring a drug to market
- How innovative chemistry can enable small groups of dedicated scientists to compete with rivals that have substantially greater resources and personnel
- Why you must always build teams composed of highly motivated individuals that possess complementary skill sets
ACS Publications Virtual Issue
Nearly 35 years after the discovery of HIV/AIDS, research is still actively ongoing to understand the virus and to develop therapeutics and vaccines. In recognition of World AIDS Day, ACS Chemical Biology, ACS Combinatorial Science, ACS Infectious Diseases, ACS Medicinal Chemistry Letters, ACS Synthetic Biology, Biochemistry, Bioconjugate Chemistry, Journal of Medicinal Chemistry, and Molecular Pharmaceutics highlight recent articles that showcase the advances made in HIV research by our ACS Authors around the world. With this Virtual Issue, we encourage the submission of research papers in this area to all participating journals. Discover more about groundbreaking advances in HIV research in this Virtual Issue.
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.
ACS External Affairs & Communications
Benefits of Membership
- ACS Webinars Archive: Every one of our 200+ past webinars available on demand
- Save Money: Members receive discounts on meetings, development courses and more!
- Access to SciFinder®: Members receive 25 complimentary SciFinder® research activities per year